NDC 0074-2600

Mavyret

Glecaprevir And Pibrentasvir

Mavyret is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Pibrentasvir; Glecaprevir.

• Product ID: 0074-2600_3be6db63-73b2-4ff3-b748-2ee10f57cdfc
• NDC: 0074-2600
• Product Type: Human Prescription Drug
• Proprietary Name: Mavyret
• Generic Name: Glecaprevir And Pibrentasvir
• Dosage Form: Pellet
• Route of Administration: ORAL
• Marketing Start Date: 2021-06-10
• Marketing Category: NDA /
• Application Number: NDA215110
• Labeler Name: AbbVie Inc.
• Substance Name: PIBRENTASVIR; GLECAPREVIR
• Active Ingredient Strength: 20 mg/1; mg/1
• Pharm Classes: Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],UGT1A1 Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],UGT1A1 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0074-2600-28

1 PACKET in 1 CARTON (0074-2600-28) > 28 PELLET in 1 PACKET

• Marketing Start Date: 2021-06-22
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Mavyret" or generic name "Glecaprevir And Pibrentasvir"

NDC	Brand Name	Generic Name
0074-2600	Mavyret	Glecaprevir and Pibrentasvir
0074-2625	Mavyret	Glecaprevir and Pibrentasvir